Search Results - "Perreault, J R"

Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region by Durbin, A P, Karron, R A, Sun, W, Vaughn, D W, Reynolds, M J, Perreault, J R, Thumar, B, Men, R, Lai, C J, Elkins, W R, Chanock, R M, Murphy, B R, Whitehead, S S

“…The recombinant dengue virus type-4 vaccine candidate 2AA30 was attenuated in rhesus monkeys due to an engineered 30-nucleotide deletion in the 3'-untranslated…”
Get more information

Improvement in weight loss and ambulation outcomes after gastric sleeve surgery for a person with chronic motor-incomplete tetraplegia: clinical case report by Perreault, J R, Geigle, P R, Gorman, P H, Scott, W H

“…Objective: To measure body mass index (BMI) and ambulation changes for a morbidly obese, 47-year-old man with chronic motor-incomplete tetraplegia after…”
Get full text

rDEN4 Delta 30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers by Durbin, A P, Whitehead, S S, McArthur, J, Perreault, J R, Blaney, JE Jr, Thumar, B, Murphy, B R, Karron, R A

“…Background. The live attenuated dengue virus type 4 (DEN-4) vaccine candidate virus rDEN4 Delta 30 was previously found to be safe and immunogenic at a dose of…”
Get full text

Changes In Consumer Attitudes Toward Marketing, Consumerism and Government Regulation: 1971-1975 by BARKSDALE, HIRAM C., DARDEN, WILLIAM R., PERREAULT, WILLIAM D.

“…Trends in consumer attitudes toward business philosophy, product quality, advertising, consumer responsibilities, government regulation and price controls are…”
Get full text